<DOC>
	<DOCNO>NCT00131053</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety treat adult ALL patient pediatric protocol .</brief_summary>
	<brief_title>Applying Pediatric Regimens Younger Adult Patients With Acute Lymphoblastic Leukemia ( ALL )</brief_title>
	<detailed_description>The prognosis adult acute lymphoblastic leukemia ( ALL ) remain poor , contrast pediatric ALL . It regard prognostic diversity attributable several difference adult child respect biological characteristic leukemic cell , tolerance anticancer drug , treatment , . It report adolescent ALL patient treat accord pediatric protocol significantly well survival treat accord adult protocol , indicate difference treatment may considerable importance . To test hypothesis , Japan Adult Leukemia Study Group ( JALSG ) plan phase 2 study treat young ALL patient negative BCR-ABL pediatric regimen use Japan Association Childhood Leukemia Study . Those positive BCR-ABL participate separate protocol . The regimen especially characterize dose-intensified L-asparaginase , high-dose methotrexate , intensified maintenance therapy .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Pirarubicin</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<mesh_term>6-Mercaptopurine</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Previously untreated BCRABLnegative ALL Age 15 24 year Performance status 0 3 ( ECOG criterion ) Adequate function liver ( serum bilirubin level &lt; 2.0 mg/dL ) ; kidney ( serum creatinine level &lt; 2.0 mg/dL ) ; heart ( leave ventricular ejection fraction great 50 % severe abnormality detect electrocardiograms echocardiograph ) . Written inform consent participate trial Uncontrolled active infection Another severe and/or lifethreatening disease Positive HIV antibody and/or hepatitis B surface ( HBs ) antigen test Another primary malignancy clinically active and/or require medical intervention Pregnant and/or lactate woman Past history renal failure</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>acute lymphoblastic leukemia</keyword>
	<keyword>newly diagnose</keyword>
	<keyword>BCR-ABL-negative</keyword>
</DOC>